{"id":"doi:10.1080/13543784.2023.2178414","kind":"review","title":"Lecanemab (BAN2401): an anti–beta-amyloid monoclonal antibody for the treatment of Alzheimer disease","authors":["Grace Vitek","Boris Decourt","Marwan Noel Sabbagh"],"author_count":3,"year":2023,"published":"2023-02-01","venue":"Expert Opinion on Investigational Drugs","cited_by":127,"doi":"10.1080/13543784.2023.2178414","arxiv_id":null,"nct_id":null,"source_url":"https://doi.org/10.1080/13543784.2023.2178414","archive_url":"https://space-kitty.com/papers/doi:10.1080/13543784.2023.2178414","updated":null,"pmid":"36749830","pmcid":null,"openalex_id":"W4319461701","pdf_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC10275297/pdf/nihms-1873229.pdf","abstract":null,"abstract_license":null,"license":null,"is_open_access":true,"retracted":false,"peer_reviewed":null,"categories":["Alzheimer's disease research and treatments"],"details":null,"provenance":"openalex","attribution":"Metadata and citation counts: OpenAlex (CC0).","topics":[{"slug":"neurodegeneration","name":"Alzheimer's, Parkinson's & Neurodegeneration","domain_slug":"medicine"}],"cited_in_dossiers":[]}